Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-01 4:10 pm Sale |
2024-02-28 | 13D | Lantern Pharma Inc. LTRN |
Bios Equity Partners LP | 1,263,802 11.800% |
-202,889 (-13.83%) |
Filing History |
| 2024-02-14 4:05 pm Sale |
2023-12-31 | 13G | Lantern Pharma Inc. LTRN |
ProPhase Labs Inc. PRPH |
631,195 5.800% |
-278,805 (-30.64%) |
Filing History |
| 2023-12-01 06:02 am Sale |
2023-11-29 | 13D | Lantern Pharma Inc. LTRN |
Bios Equity Partners LP | 1,466,691 13.600% |
-508,150 (-25.73%) |
Filing History |
| 2022-11-21 4:15 pm Purchase |
2022-11-08 | 13G | Lantern Pharma Inc. LTRN |
ProPhase Labs Inc. PRPH |
910,000 8.400% |
910,000 (New Position) |
Filing History |
| 2022-03-22 4:15 pm Purchase |
2022-03-17 | 13D | Lantern Pharma Inc. LTRN |
Bios Equity Partners LP | 1,974,841 18.100% |
5,855 (+0.30%) |
Filing History |
| 2022-01-11 10:31 am Sale |
2021-12-31 | 13G | Lantern Pharma Inc. LTRN |
Empery Asset Management, LP | 0 0.000% |
-700,000 (Position Closed) |
Filing History |
| 2021-02-16 4:02 pm Purchase |
2020-12-31 | 13G | Lantern Pharma Inc. LTRN |
Green Park & Golf Ventures LLC | 672,758 6.400% |
672,758 (New Position) |
Filing History |
| 2021-02-16 1:15 pm Purchase |
2020-12-31 | 13G | Lantern Pharma Inc. LTRN |
Asaithambi Arunkumar | 470,460 4.500% |
470,460 (New Position) |
Filing History |
| 2021-01-25 09:41 am Purchase |
2021-01-14 | 13G | Lantern Pharma Inc. LTRN |
Empery Asset Management, LP | 700,000 6.660% |
700,000 (New Position) |
Filing History |
| 2020-06-23 3:17 pm Purchase |
2020-06-15 | 13D | Lantern Pharma Inc. LTRN |
Bios Equity Partners LP | 1,968,986 30.600% |
1,968,986 (New Position) |
Filing History |
| 2020-06-22 5:46 pm Purchase |
2020-06-15 | 13D | Lantern Pharma Inc. LTRN |
BIOLOGICAL MIMETICS INC | 1,058,231 17.000% |
1,058,231 (New Position) |
Filing History |
| 2020-06-19 4:05 pm Purchase |
2020-06-15 | 13D | Lantern Pharma Inc. LTRN |
SHARMA PANNA | 495,486 7.400% |
495,486 (New Position) |
Filing History |